NystoseCAS# 13133-07-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 13133-07-8 | SDF | Download SDF |
PubChem ID | 166775 | Appearance | Powder |
Formula | C24H42O21 | M.Wt | 666.58 |
Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
Solubility | H2O : 300 mg/mL (450.06 mM; Need ultrasonic and warming) | ||
Chemical Name | (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | ||
SMILES | C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)COC3(C(C(C(O3)CO)O)O)COC4(C(C(C(O4)CO)O)O)CO)O)O)O)O | ||
Standard InChIKey | FLDFNEBHEXLZRX-DLQNOBSRSA-N | ||
Standard InChI | InChI=1S/C24H42O21/c25-1-8-12(30)16(34)17(35)21(41-8)45-24(20(38)15(33)11(4-28)44-24)7-40-23(19(37)14(32)10(3-27)43-23)6-39-22(5-29)18(36)13(31)9(2-26)42-22/h8-21,25-38H,1-7H2/t8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18+,19+,20+,21-,22-,23-,24+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Nystose has antioxidant capacity. Nystose and 1-Kestose can modulate the intestinal Microorganisms flora, a high content of kestose and nestose in the diet can cause a decrease in ileal and cecal pH (to 5.42 and 5.49, respectively)of turkeys, which may promote digestion. |
Targets | IFN-γ | IL Receptor |
In vitro | In vitro anti‐hydroxyl radical activity of the fructooligosaccharides 1‐kestose and nystose using spectroscopic and computational approaches[Reference: WebLink]Int. J. Food Sci. Tech., 2014, 49(6):1500-5.Fructooligosaccharides (FOS) are bioactive oligosaccharide fructans with beneficial health effects. Anti‐hydroxyl radical activity is an important factor in the description of antioxidant capacity of any natural product. |
In vivo | Effect of a kestose and nystose preparation on growth performance and gastrointestinal tract function of turkeys.[Pubmed: 17495083]Poult Sci. 2007 Jun;86(6):1133-9.The aim of the present study was to determine the effects of dietary administration of a fructooligosaccharide preparation rich in kestose and nestose on growth performance and gastrointestinal parameters in young turkeys. Effects of 1-Kestose and Nystose on the Intestinal Microorganisms and Immune System in Mice.[Reference: WebLink]J. Appl. Glycosci., 2006, 53(3):175-80.
|
Structure Identification | Food Chem. 2015 Dec 1;188:658-63.Comparative study on the effects of nystose and fructofuranosyl nystose in the glycation reaction on the antigenicity and conformation of β-lactoglobulin.[Pubmed: 26041244]Our previous work indicated that the antigenicity of bovine β-lactoglobulin (β-LG) decreased after conjugation with fructo-oligosaccharides (FOS) which was related to its conformational changes. |
Nystose Dilution Calculator
Nystose Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.5002 mL | 7.501 mL | 15.002 mL | 30.0039 mL | 37.5049 mL |
5 mM | 0.3 mL | 1.5002 mL | 3.0004 mL | 6.0008 mL | 7.501 mL |
10 mM | 0.15 mL | 0.7501 mL | 1.5002 mL | 3.0004 mL | 3.7505 mL |
50 mM | 0.03 mL | 0.15 mL | 0.3 mL | 0.6001 mL | 0.7501 mL |
100 mM | 0.015 mL | 0.075 mL | 0.15 mL | 0.3 mL | 0.375 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- threo Ifenprodil hemitartrate
Catalog No.:BCC7508
CAS No.:1312991-83-5
- Ro 8-4304 hydrochloride
Catalog No.:BCC7655
CAS No.:1312991-77-7
- Ro 25-6981 Maleate
Catalog No.:BCC4159
CAS No.:1312991-76-6
- Scutebarbatine Z
Catalog No.:BCN6991
CAS No.:1312716-28-1
- Scutebarbatine Y
Catalog No.:BCN6994
CAS No.:1312716-27-0
- Scutebarbatine X
Catalog No.:BCN6997
CAS No.:1312716-26-9
- Scutebarbatine W
Catalog No.:BCN7011
CAS No.:1312716-25-8
- Antibiotic PF 1018
Catalog No.:BCN2149
CAS No.:131256-42-3
- PF 5081090
Catalog No.:BCC6148
CAS No.:1312473-63-4
- Cornuside
Catalog No.:BCN5007
CAS No.:131189-57-6
- NSC 624206
Catalog No.:BCC7988
CAS No.:13116-77-3
- Sodium Demethylcantharidate
Catalog No.:BCN8394
CAS No.:13114-29-9
- NVP-CGM097
Catalog No.:BCC5395
CAS No.:1313363-54-0
- erythro-Guaiacylglycerol beta-threo-syringylglycerol ether
Catalog No.:BCN7333
CAS No.:1313434-74-0
- Periplocin
Catalog No.:BCN2655
CAS No.:13137-64-9
- Teijin compound 1
Catalog No.:BCC6057
CAS No.:1313730-14-1
- Boc-Trp-OH
Catalog No.:BCC3455
CAS No.:13139-14-5
- Boc-Leu-OH.H2O
Catalog No.:BCC3408
CAS No.:13139-15-6
- Boc-Ile-OH.1/2H2O
Catalog No.:BCC3406
CAS No.:13139-16-7
- CBZ-Osu
Catalog No.:BCC2798
CAS No.:13139-17-8
- Hemopressin (human, mouse)
Catalog No.:BCC6065
CAS No.:1314035-51-2
- TC-N 22A
Catalog No.:BCC6150
CAS No.:1314140-00-5
- UNC669
Catalog No.:BCC3997
CAS No.:1314241-44-5
- Cercosporamide
Catalog No.:BCC2438
CAS No.:131436-22-1
Comparative study on the effects of nystose and fructofuranosyl nystose in the glycation reaction on the antigenicity and conformation of beta-lactoglobulin.[Pubmed:26041244]
Food Chem. 2015 Dec 1;188:658-63.
Our previous work indicated that the antigenicity of bovine beta-lactoglobulin (beta-LG) decreased after conjugation with fructo-oligosaccharides (FOS) which was related to its conformational changes. In attempt to unravel further changes of beta-LG antigenicity, Nystose (GF3) and 1(F)-beta-fructofuranosyl Nystose (GF4) of FOS were used to investigate the relationship between conformation and antigenicity. The antigenicity of beta-LG after conjugated with GF3 and GF4 decreased from 143.4 to 29.5 and 31.6 mug/mL, respectively. The results of mass spectrometry revealed that the molecular weight of beta-LG increased from 18.4 to 19.8 and 19.1 kDa after conjugation with GF3 and GF4, respectively. It was shown that the conformational changes of beta-LG after conjugation with GF3 were bigger than that with GF4, including quenching of fluorescence intensity, the red-shift of fluorescence spectra, and the increase in sulfhydryl content. However, there was no significant difference in the antigenicity between beta-LG-GF3 and beta-LG-GF4 conjugates (P>0.05).
Effect of a kestose and nystose preparation on growth performance and gastrointestinal tract function of turkeys.[Pubmed:17495083]
Poult Sci. 2007 Jun;86(6):1133-9.
The aim of the present study was to determine the effects of dietary administration of a fructooligosaccharide preparation rich in kestose and nestose on growth performance and gastrointestinal parameters in young turkeys. The kestose and nestose preparation was obtained through bioconversion of sucrose using fungi fructosyl transferase and contained in DM 39.9% of kestose, 17.6% of Nystose, as well as 26.5% of glucose and 14.7% of sucrose. Three dietary levels of the sum of kestose and Nystose (0.3, 0.6, and 1.2%) were fed to growing turkeys for 8 wk. When compared with the control treatment, addition of the kestose and nestose preparation had no effect on feed intake, feed conversion, and BW. The kestose and nestose-supplemented diet, especially the medium level of kestose and Nystose, influenced microbial metabolism, especially in the ceca. Compared with the control group, the medium level of kestose and nestose decreased relative weight of gizzard (from 18.67 to 16.51 g/kg of BW) and weight of small intestine tissue (from 23.3 to 19.6 g/kg of BW) and increased weight of ceca digesta (from 3.51 to 4.77 g/kg of BW) as well as activities of microbial beta-glucosidase (an increase from 0.22 to 0.38 U/g) and alpha-galactosidase (an increase from 0.90 to 1.61 U/g), pH of digesta (a decrease from 6.13 to 5.79), concentration of NH3 (an increase from 0.60 to 0.98 mg/g), and concentration of total short-chain fatty acids (an increase from 81.1 to 107.7 micromol/g) in the cecal digesta. A high content of kestose and nestose in the diet caused a decrease in ileal and cecal pH (to 5.42 and 5.49, respectively).